Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study
Authors
Keywords
-
Journal
Infectious Diseases and Therapy
Volume 10, Issue 3, Pages 1379-1390
Publisher
Springer Science and Business Media LLC
Online
2021-05-29
DOI
10.1007/s40121-021-00423-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China
- (2020) Shuchang Zhou et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
- (2020) Wei Zhang et al. Emerging Microbes & Infections
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
- (2020) Ahmet Kursat Azkur et al. ALLERGY
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
- (2020) Spyridon G. Deftereos et al. Hellenic Journal of Cardiology
- Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
- (2020) Yujiao Jin et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Can melatonin reduce the severity of COVID-19 pandemic?
- (2020) Alex Shneider et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
- (2020) Tao Chen et al. BMJ-British Medical Journal
- Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China
- (2020) Xintian Liu et al. Aging-US
- SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity
- (2020) William S Phipps et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The clinical course and its correlated immune status in COVID-19 pneumonia
- (2020) Ruyuan He et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
- (2020) Barnaby E Young et al. CLINICAL INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
- (2015) Jasper F. W. Chan et al. CLINICAL MICROBIOLOGY REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started